Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?

American Journal of Gastroenterology

Volumn 94, Issue 11, 1999, Pages 3184-3188

  Lin, Hwai Jeng ^a   Tseng, Guan Ying ^a   Hsieh, Yu Hsi ^a   Perng, Chin Lin ^a   Lee, Fa Yauh ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DUODENUM BLEEDING; ENDOSCOPIC THERAPY; FEMALE; HELICOBACTER PYLORI; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH HEMORRHAGE; STOMACH PH;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BLOOD TRANSFUSION; CONFIDENCE INTERVALS; DUODENAL ULCER; DUODENOSCOPY; FEMALE; GASTRIC FUNDUS; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMOSTATIC TECHNIQUES; HUMANS; HYDROGEN-ION CONCENTRATION; LENGTH OF STAY; MALE; MIDDLE AGED; OMEPRAZOLE; RECURRENCE; STOMACH ULCER; SURVIVAL RATE; UREASE;

EID: 0032704808     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00575-4     Document Type: Article

References (32)

1. Consensus statement on therapeutic endoscopy and bleeding ulcers. Gastrointest Endosc. 36:1990;S62-S65.
2. Lin H.J., Lee F.Y., Kang W.M., et al. Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage A prospective, randomized controlled trial . Gut. 31:1990;753-757.
3. Lin H.J., Wang K., Perng C.L., et al. Heat probe thermocoagulation and multipolar electrocoagulation for arrest of peptic ulcer bleeding A prospective, randomized comparative trial . J Clin Gastroenterol. 21:1995;99-102.
4. Laine L. Multipolar electrocoagulation versus injection therapy in the treatment of bleeding peptic ulcers A prospective, randomized trial . Gastroenterology. 99:1990;1303-1306.
5. Laine L., Hopkins R.J., Girardi L.S. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol. 93:1998;1409-1415.
6. Labenz J., Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol. 89:1994;1785-1788.
7. Rokkas T., Karameris A., Mavrogeorgis A., et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 41:1995;1-4.
8. Jaspersen D., Koerner T., Schorr W., et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 41:1995;5-7.
9. Riemann J.F., Schilling D., Schauwecker P., et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc. 46:1997;299-304.
10. Macri G., Milani S., Surrenti E., et al. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding A long-term follow-up study . Am J Gastroenterol. 93:1998;925-927.
11. Smout A.J.P.M. Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent? Scand J Gastroenterol. 33:(suppl 225):1998;32-35.
12. Labenz J., Tillenburg B., Peitz U., et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology. 110:1996;725-732.
13. Verdú E.F., Armstrong D., Idström J.P., et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut. 37:1995;743-748.
14. Verdú E.F., Armstrong D., Fraser R., et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut. 36:1995;539-543.
15. Khuroo M.S., Yattoo G.N., Javid G., et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 336:1997;1054-1058.
16. Reynolds J.R., Walt P.R., Clark A.G., et al. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine. Aliment Pharmacol Ther. 1:1987;23-30.
17. Gralnek I.M., Jensen D.M., Gornbein J., et al. Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel An analysis of two prospective clinical trials . Am J Gastroenterol. 93:1998;2047-2056.
18. Brunner G., Luna P., Thiesemann C. Drugs for pH control in upper gastrointestinal bleeding. Aliment Pharmacol Ther. 9:1995;47-50.
19. Lin H.J., Lo W.C., Lee F.Y., et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 158:1998;54-58.
20. Lin H.J., Perng C.L., Lee F.Y., et al. Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels A prospective study . Gut. 35:1994;1389-1393.
21. Lin H.J., Perng C.L., Wang K., et al. Long-term results of heater probe thermocoagulation for patients with massive peptic ulcer bleeding A prospective observation . Am J Gastroenterol. 90:1995;44-47.
22. Lin H.J., Wang K., Perng C.L., et al. Natural history of bleeding peptic ulcers with a tightly adherent blood clot A prospective observation . Gastrointest Endosc. 43:1996;470-473.
23. Laine L., Peterson W.L. Bleeding peptic ulcer. N Engl J Med. 331:1994;717-727.
24. Taguchi Y., Kaito M., Gabazza E.C., et al. Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. Scan J Gastroenterol. 32:1997;656-663.
25. Triebling A.T., Korsten M.A., Dulgosz J.W., et al. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci. 36:1991;1089-1096.
26. Mobley H.L.T., Hausinger R.P. Microbial ureases Significance, regulation and molecular characterization . Microbiol Rev. 53:1989;85-108.
27. + ATPase. Gut. 35:1994;1176-1180.
28. Cave D.R., Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet. ii:1989;187-191.
29. Taché Y., Sapera E. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1a. Ann NY Acad Sci. 664:1992;353-368.
30. Borody T.J., Andrews P., Jankiewicz E., et al. Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. Am J Gastroenterol. 88:1993;1266-1268.
31. Yasunaga Y., Shinimura Y., Kanayama S., et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori-associated enlarged fold gastritis. Gut. 35:1994;1571-1574.
32. Jensen D.M., You S., Pelayo E., et al. The prevalence of Helicobacter pylori and NSAID use in patients with severe UGI haemorrhage and their portential role in recurrence of ulcer bleeding. Gastroenterology. 102:1992;A85.